US Patent 7317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives
Patent 7317016 was granted and assigned to Bayer on January, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Achim Feurer0
Alexander Straub0
Cristina Alonso-Alija0
Dieter Lang0
Dietmar Flubacher0
Elisabeth Perzborn0
Elke Stahl0
Frank Wunder0
Johannes-Peter Stasch0
Klaus Dembowsky0
Stefan Weigand0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+224 characters)
Article
Patent abstract
This invention relates to methods of treatment of cardiovascular disorders, thromboembolic disorders, inflammation, and disorders of the central nervous system using pyrazol pyridine derivatives of formula (I)
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives US Patent 7317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives
Infobox
Patent Number
07317016
Patent Number
7317016
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07317016
Date of patent
January 8, 2008
Patent application number
11175740
Date Filed
July 5, 2005
Patent primary examiner
Find more entities like US Patent 7317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
